To Evaluate the Efficacy and Safety of Wenxin Keli in Treating Atrial Premature Beats
Status:
Unknown status
Trial end date:
2017-02-01
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, two dose group, parallel-control multi-center, post-marketing
clinical trial，to evaluate the efficacy and safety of Wenxin keli in treating atrial
premature beats by different dose,to provide a scientific basis for rational clinical use of
drug.